There are many problems with #Covaxin #vaccine, contrary to the article tweeted multiple times at me.
In April @WHO blocked it because science.org/content/articl…
The company's study offered no antibody info on placebo users to compare efficacy of vax to medrxiv.org/content/10.110…
MORE
In April @WHO blocked it because science.org/content/articl…
The company's study offered no antibody info on placebo users to compare efficacy of vax to medrxiv.org/content/10.110…
MORE
https://twitter.com/doc_holliday50/status/1532741870576467968
2/
Exportation from India was halted on April 2 after @WHO discovered manufacturing contamination mail.google.com/mail/u/0/#sear…
An Indian study found 2-dose #Covaxin only 47% effective against #SARSCoV2 despite manufacturer claim of 93%. doi.org/10.1016/S1473-…
BUT...
MORE
Exportation from India was halted on April 2 after @WHO discovered manufacturing contamination mail.google.com/mail/u/0/#sear…
An Indian study found 2-dose #Covaxin only 47% effective against #SARSCoV2 despite manufacturer claim of 93%. doi.org/10.1016/S1473-…
BUT...
MORE
3/
#Covaxin can be stored at 47 degrees F, unlike the super-cold required for mRNA vaccines. That's a big plus.
Still, head-on-head independent comparisons of #COVID19 #vaccines against #Omicron found the Bharat-made Covaxin performed poorly.
nature.com/articles/d4158…
MORE
#Covaxin can be stored at 47 degrees F, unlike the super-cold required for mRNA vaccines. That's a big plus.
Still, head-on-head independent comparisons of #COVID19 #vaccines against #Omicron found the Bharat-made Covaxin performed poorly.
nature.com/articles/d4158…
MORE
4/ It is best to judge #vaccines based on studies, when available, that were NOT performed by the manufacturer. And it's always a good idea to separate data and politics.
@WHO has approved 11 #COVID19 vaxs for ER use, including #Covaxin for adults extranet.who.int/pqweb/vaccines…
MORE
@WHO has approved 11 #COVID19 vaxs for ER use, including #Covaxin for adults extranet.who.int/pqweb/vaccines…
MORE
5/
Only 7 vaccines had applied for indemnity, allowing humanitarian use by NGOs, UN agencies and poor countries thru #COVAX w/out legal liability issues --#Covaxin is NOT one of them. Neither are @pfizer or @moderna . This greatly limits their use. gavi.org/covax-facility
MORE
Only 7 vaccines had applied for indemnity, allowing humanitarian use by NGOs, UN agencies and poor countries thru #COVAX w/out legal liability issues --#Covaxin is NOT one of them. Neither are @pfizer or @moderna . This greatly limits their use. gavi.org/covax-facility
MORE
6/
#Covaxin has been approved by 14 countries, says @WHO.
@pfizer vaccine has been approved by 146 countries; J&J in 111;
AstraZeneca in 140;
and India's other vax, CoviShield is in 49 countries.
covid19.trackvaccines.org/agency/who/
#Covaxin has been approved by 14 countries, says @WHO.
@pfizer vaccine has been approved by 146 countries; J&J in 111;
AstraZeneca in 140;
and India's other vax, CoviShield is in 49 countries.
covid19.trackvaccines.org/agency/who/
• • •
Missing some Tweet in this thread? You can try to
force a refresh
